Home » Topics » Regulatory

Regulatory
RSS

Topline results from pivotal Metformin GR study

Dec. 16, 2003

Allergan and Inspire sign copromotion agreement for Elestat

Dec. 11, 2003

Preliminary phase III results for Vivitrex show reductions in heavy drinking

Dec. 11, 2003

Risperdal approved for bipolar mania

Dec. 10, 2003

Cipralex approved in select European countries for social anxiety disorder

Dec. 9, 2003

U.S. launch of Risperdal Consta

Dec. 9, 2003

Zorbtive receives FDA approval for short bowel syndrome

Dec. 5, 2003

Sepracor reports phase III program results for Xopenex HFA MDI

Dec. 4, 2003

German approval for Leuprogel one-month depot product

Dec. 4, 2003

Gadovist 1.0 receives E.U. approval for MRA

Dec. 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.